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The Identification and Determination of Barbiturates in Serum
By Υ. A. SINNEAIA
From the Clinical Chemical Laboratory (Head: H. J. Peters) St. Canis'ms Hospital., Nijwegen, The Netherlands
(Eingegangen am 3. M rz 1966)
The identification of barbiturates is based on the difference in the distribution coefficients of various barbiturates
between chloroform and each of two aqueous alkaline solutions and, furthermore, on differences in the shapes of
the absorption spectra for the enol forms of various barbiturates.
The identification and quantitative determination is performed by extracting the serum containing a barbiturate,
at pH 7.4 with 50 times its volume of chloroform. Part of the chloroform layer is extracted with dilute NaOH and
the absorption of the extract at 230, 240 and 250 m μ is measured at pH 10 and pH 2. Another portion of the chloro-
form layer is extracted \vith Na2HPO4 (pH 8.9). The type of barbiturate present is determined from the difference in
absorption at 240 τημ of this extract at pH 8.9 and pH 2, together with the previous absorption differences at 240 and
250 τημ.
The concentration of the barbiturate in serum is calculated from the difference in absorption at 240 τημ of solutions
at pH 10 and pH 2, using a reference curve for barbital. The value found in this way is multiplied by the appropiate
barbiturate factor to give the correct concentration.
The confirmation of barbiturate poisoning is a qualitative as well as a quantitative problem. Before the onset of
toxic symptoms, the blood levels of the long^acting barbiturates, such as phenobarbital (luminal) and barbital
(veronal), are much higher than those of the short-acting ones, such as hexabarbital (N-methylcyclohexenyl methyl
barbital = evipan). Barbiturates with medium action, such as butobarbital (soneryl), pentobarbital (nembutal) and
allobarbital (dial) also show intermediate blood levels.
Die Auftrennung von Barbituraten beruht auf der Verschiedenheit der Verteilungskoeffizienten verschiedener
Barbiturate zwischen Chloroform und zwei alkalisch-w rigen L sungen, sowie auf den Unterschieden in der Form
der Absorptionsspektren f r die Enolformen verschiedener Barbiturate.
Die Identifizierung und quantitative Bestimmung wird durch Extraktion des B rbiturat enthaltenden Serums bei
pH 7,4 mit dem SOfachen Volumen Chloroform der Ausgangsserummenge vorgenommen. Ein Teil der Chloro-
formschicht wird mit verd nnter NaQH ausgezogen und die Absorption des Extraktes bei 230, 240 und 250 τημ bei
pH 10 und pH 2 gemessen. Ein zweiter Teil der Chloroformschicht wird mit NagHPC^ (pH 8,9) extrahiert. Der
anwesende Barbiturattyp wird aus der Differenz in der Absorption dieses Extraktes bei 240 τημ bei pH 8,9 und
pH 2,0 — zusammen mit den obengenannten Absorptionsdifferenzen bei 240 und 250 τημ — berechnet.
Die Konzentration des Barbiturates im Serum wird aus der Absorptionsdifferenz bei 240 τημ der L sungen bei
pH 10 und pH 2 berechnet, wobei eine Bezugskurve f r Barbiturs ure verwendet wird. Der auf diese Weise ge-
fundene Wert wird mit dem passenden Barbituratfaktor multipliziert und ergibt so die korrekte Konzentration.
SUNSHINE (I) reviewed the correlation between the
concentrations of different barbiturates in blood and the
established clinical condition. — Comatosis may appear
at a blood concentration of 65 mg// for a long-acting
barbiturate, 45 mg// for an intermediates-acting and
25 mg// for a short-acting one. — To determine the
seriousness of a barbiturate poisoning in a comatose
state, it is — in addition to the determination of its
concentration in serum ^- important to know, which
barbiturate is present or to which group (long, medium,
or short acting) it belongs. Generally, when the patient
is not comatose, there will be little necessity to know
which barbiturate was taken. Therefore, the identi-
fication of barbiturates in most cases will only be
necessary if their concentrations in the serum are
relatively high.
Several spectrophotometric methods for the quantitative
determination and identification of barbiturates are des-
cribed in the literature (2—8). Identification methods
for barbiturates are described by STEVENSON (2), HELL-
DORF (5) and GOLDBAUM (4). VAN HAERINGEN (3) gave
a review and a critical examination of several of these
methods. For quantitative determination it appeared
that the extraction of acidified serum with a large excess
of chloroform and determination of the absorption at
240 πιμ in a buffer solution of pH 10 and at pH 2 gave
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the most satisfactory results. The method according to
GOLDBAUM (4) gives an indication of the type of barbi-
turate, but does not identify it specifically.
Method
Barbiturates can exist in two tautomeric forms, viz, the
enol-form and the keto-form, depending on the pH of
the solution. The absorption maximum for barbiturates
in weakly alkaline solutions (pH 8.9 and pH 10) is
caused by the enol-form and appears at approximately
240 m^, with slight variations for the various barbi-
turates. In acid solutions (pH 2) the barbiturates exist
in the keto-form and show no absorption at 240 ιημ. It
must be supposed that the physical properties of a
barbiturate, as well as the formation of its enol-or keto-
form, at any given pH, are influenced by its substituents.
Indeed, DYBING (7) reported that the distribution coeffi-
cients of various barbiturates between chloroform and
an aqueous solution showed large differences at the same
alkaline pH. He also indicated that the distribution
coefficients for one barbiturate between chloroform and
aquous solutions of different alkalinities may differ
considerably.
The findings of DYBING are confirmed by our investi-
gations. The identification of barbiturates, according to
the method described below, is based on the difference in
distribution coefficients of the various barbiturates be-
tween chloroform and two aqueous alkaline solutions
and furthermore on the difference of the absorption
curves for the enolforms of the various barbiturates.
Three sera, each containing 200 mg of a different barbi-
turate, were submitted to the identification and deter-
mination procedures described below. The sera were
extracted with chloroform. One part of each solution
was extracted with an aqueous solution, pH 8.9. The
other part was extracted with 0.1 N NaOH to extract the
maximum quantity of barbiturate. This alkaline solution
was adjusted to pH 10 with boric acid to ensure that the
barbiturates were present in the mono-enol form (7).
Absorption difference curves between the aqueous
solution of pH 10 and pH 2, as well as those of pH 8.9
and pH 2, for wavelengths between 225 and 260 ηιμ,
are shown in figure 1.
Figure 1 shows that the absorption differences at 240 τημ
between pH 8.9 and pH 2 and those between pH 10 and
pH 2 show ratios that are quite different for each of the
barbiturates, although their initial weight concentrations
in serum are equal. The different ratios are explained by
the different distribution coefficients of the barbiturates
between the chloroform and the alkaline solutions. The
identification of a barbiturate can be achieved on this
basis,^and by using the ratio of the differences in ab-
sorption at 240 and 250 ιημ with solutions of pH 10 and
pH 2. This ratio is more or less different for each of the
barbiturates, and is caused by the different slopes of the
absorbance difference curves between 240 and 260 πιμ.
From the determined absorption for each barbiturate,
two parameters are composed that are placed as absis
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Fig. 1
Spectral absorption difference curves of barbiturates between
aqueous solutions of pH 10 and pH 2 as well as those of pH 8.9
and pH 2, obtained from sera containing 200 mg// barbiturate
and ordinate in a graph. Parameter 7, defined as the ratio
at 240 and 250 τημ of the absorption differences between
pH 10 and pH 2, is placed on the absis in a graph.
Parameter I =
A pH 10-2
240 m,tt
A pH 10—2
250 ιημ
On the ordinate of the graph is placed parameter 77, which
indicates the ratio of the absorption differences between
solutions of pH 8.9 and pH 2, and those between so-
lutions of pH 10 and pH 2 for 240 ηιμ.
Parameter II =
A pH 8.9—2
240 ιημ
A pH 10—2
240 τημ.
In this way every barbiturate has its own place in the
graph (fig. 2), although there is some overlapping. The
quantitative determination of a barbiturate in serum is
performed according to a reliable method reported by
. VAN HAERINGEN (2), using the linear relation between
the measured absorption differences at 240 m/j in the
solutions of pH 10 and pH 2, and the barbiturate con-
centration in the serum. This relation is different for
various barbiturates as shown in figures 3 a and 3b. This
method· for quantitative determination and slight
variations of it, have been described previously by
WALKER c.s. (6), DYBING (7) and Lous (8).
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Identification and determination
Reagents
Phosphate buffer pH 7.4: 0.908 g KH2PO4 and 4.750 g Na2HPO4 ·
2H2O are dissolved in 100 ml distilled water.
Chloroform, redistilled, bp. 59—61°.
0.lNNaOH(A.R.).
Boric acid solution: 6.2 g boric acid (A.R.) in 1 / 0.1 N KC1. A
mixture of equal volumes of this solution and 0.1 N NaOH should
form a buffer with pH 10 · 0 (test with indicator paper).
4N HC1.
Phosphate solution of pH 8.9: 8.90 g Na2HPO4 · 2H2O (A.R.) are
dissolved in 250 m/ distilled water.
Procedure
Extraction of sample with chloroform
Add to a 100 m/ separating funnel, 1 m/ serum, 0,4 m/ phosphate
buffer of pH 7.4 and 55m/ redistilled chloroform; shake for
5 minutes.
After separation, the chloroform solution is placed in a dry receiver,
which is closed with a stopper and used for the extraction pro-
cedures at pH 8.9 and pH 10.
Procedure at pH 8.9
25 m/ of the chloroform solution, in a 100 m/ separating funnel,
are extracted with 6 m/ disodium hydrogen-ortho-phosphate
solution (pH 8.9) by shaking for 5 minutes. After separation, the
chloroform layer is removed and the ortho-phosphate solution is
centrifuged for 5 minutes at 3000 rpm.
The absorption of the clear solution is determined with a spectro-
photometer in a quartz cuvette at 240 mμ. 6 Drops of 4 N HC1 are
then added to the solution in the cuvette so that the pH becomes 2
or less (test with indicator paper) and the absorption is determined
again at 240 τημ. The absorption at pH 2 is substracted from that
at pH 8.9.
Procedure at pH 10
25 m/ of the chloroform solution, in another 100 m/ separating
funnel, are extracted with 6m/ of 0.1 N NaOH by shaking for
5 minutes. The chloroform layer is removed and the NaOH solution
is centrifuged for 5 minutes at 3000 rpm. 3.0 m/ of the clear
solution are transferred to a test tube with a pipette and mixed
with 3.0 m/ of boric acid solution. The mixture now has pH 10.0.
The absorption of this solution is determined with a spectrophoto-
meter in quartz cuvettes at 230, 240 and 250 mμ.
2 Drops of 4N HC1 are then added to the solutions in the cuvettes.
Now the pH is 2 or less (test with indicator paper). The absorption
is determined again at 230, 240 and 250 mμ. The values at pH 2
* are substracted from those at pH 10.0. A barbiturate is present, if
the absorption differences show a maximum at 240 ιημ (see note 2).
Notes
If the absorption at 240 mμ and pH 2 for the "procedure at pH 10"
is higher than 0.150 and for the "procedure at pH 8.9" is higher
than 0.100, an interfering substance may be present. The chloro-
form solution should then be washed twice with 1m/ of 30%
H2SO4, once with 1 m/ of water and finally once with 0.5 m/ of
phosphate buffer, pH 7.4.
For prominal the maximum is found at 250 mμ; however the ab-
sorption difference at 240 mμ is definitely greater than that at 230 τημ.
Identification .
The substance is plotted in the barbiturate diagram (fig. 2) by
glacing the value of parameter I on the absis and that of parameter II
on the ordinate. The determined position indicates the identity of
the barbiturate present.
Determination of the concentration in the serum
The barbiturate concentration is determined from the absorption
differences between pH 10 and pH 2 at 240 τημ, by comparison with
those of a calibration curve for barbital (fig. 3). The determined
concentration is multiplied by the appropiate barbiturate factor.
Example
Identification and determination of serum samples A and B,
containing 100 mg// each of phenobarbital and aliobarbital, re-
spectively.
pH of solution 230
A
8.9
2
difference
10.0 .365
2 .244
difference .121
Parameter I:
Parameter II:
Identification :
Barbiturate factor:
Absorpt ion at
mμ 240 mμ 250 m/t
B A B A B
.264 .201
.051 .037
.213 .164
.306 .320 .288
.204 .148 1.26
.102 .172 .162
Substance A
·
172
 - 1 50
.114
.213
— 1 9A
.172
phenobarbital
1.3
.238 .206
.124 .103
.114 1.03
Substance Β
·
162
 158
.103
·
164
 ι ο ί
.162
aliobarbital
1.2
Concentration in serum: 81X 1.3 = 105 mg// 76 X 1.2 = 91 mg//
Discussion and Results
Identification
To identify a barbiturate in a case of poisoning we direct
ourselves in first place to those substances that are used
in a definite country or region and especially to those,
that are easily available to the public. Table 1 shows a
survey of the values of parameters I and II composed
from ten determinations for each of the various bar-
biturates.
Figure 2 shows the places of the substances mentioned in
table 1, in a barbiturate graph. The places are obtained
by placing in the graph for each of the barbiturates the
mean values of parameters I and II plus or minus twice
their standard deviations. This means that 95% of all
possible plots for a barbiturate in the diagram are covered
by the areas of the indicated place.
The xong-acting barbital, phenobarbital and hepto-
barbital are found in the higher part of the diagram.
Methylphenobarbital, a N-methyl barbital, which is also
a long-acting barbiturate, however is found in the lower
part of the diagram. Of the examined barbiturates,
heptobarbital (rutonal), methyl phenobarbital (pro-
minal), hexabarbital (evipan), barbital (veronal), pheno-
barbital (luminal) and aliobarbital can be identified.
Butobarbital * (soneryl), heptabarbital (medomin) and
pentobarbital (nembutal) cannot be distinguished from
each other.
Evaluation of concentration
For various barbiturates, the absorption differences at
240 m/^ between solutions of pH 10 and pH 2, are
different for equal weight concentrations as shown in
table 2.
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Tab. 1
Parameters I, II and barbiturate factors for several barbiturates
Barbiturate
Methyl phenobarbital
Hexabarbital
Pentobarbitai-Na
Heptabarbital
Butobarbital
Cyclobarbital-Ca
Aprobarbital
Allobarbital
Phenobarbital
Barbital
Heptobarbital
(prominal)
(evipan)
(nembutal)
(medomin)
(soneryl)
(phanodorm)
(dial)
(luminal)
(veronal)
(rutonal)
Mol.
weight
246
234
248
250
212
275
210
208
232
184
218
Parameter I
Mean*
0.91
1.11
1,70
1.80
1.86
1.62
1.53
1.53
1.52
1.86
1.52
Stand, dev. *
0.047
0.049
0.050
0.067
0.080
0.062
0.034
0.048
0.070
0.113
0,042
Parameter Π
Mean*
0.17
0.12
0.20
0.28
0.30
0.44
0.56
0.96
1.15
1.36
1.90
Stand, dev.*
0.120
0.065
0.090
0.060
0.045
0.048
0.055
0.058
0.060
0.083
0.180
Barbiturate
factor
2.1
1.8
1.3
1.3
1.0
1.1
1.2
1.2
1.3
1.0
1.8
* Calculated from 10 determinations for each of the barbiturates
2.2
1.8
1.6
^
I
^10
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02
0
0
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Fig. 2
Barbiturate diagram,
of barbiturate expressed in parameters I and II
icnobarbital (prominal) A = aprobarbital
tal (evipan) D = allobarbital (dial)
iital (nembutal) L = phcnobarbital (luminal)
>ital (medomin) V = barbital (veronal)
tal (soneryl) H = heptobarbital (rutonal)
ital (phanodorm)
Figures 3 a and 3b show the graphical representation oi
the data mentioned in table 2.
It is evident that for the determination of the barbiturate
concentration in serum we have to use the corresponding
calibration line for the barbiturate that is present. In
practice it will be more convenient to use only the
calibration curve for barbital and to multiply the de-
termined concentration with a factor corresponding to
the barbiturate that is present. This barbiturate factor
indicates the weight concentration ratio for equal ab-
sorbances between a barbiturate and barbital.
A survey of the barbiturate factors for several generally
known barbiturate obtained from figure 3 a, b is given
in table 1. The barbiturate factors correspond rather well
with the molar ratios of the barbiturates with respect to
barbital, except methyl phenobarbital, hexabarbital,
heptobarbital and cyclobarbital.
The mean absorption difference for 18 sera without
barbiturate was 0.017. In figures 3 a and 3b all curves are
Tab. 2
Absorption differences at 240 ιημ between pH 10 and pH 2 for
various barbiturates at several serum* concentrations*)
Absorption differences at 240 τημ obtained
for a barbiturate concentration in serum of
Barbiturate mg/7:
50 67 100 . 133 150 160
Barbital
Butobarbital
Cyclobarbital
Allobarbital
Aprobarbital
Pentobarbital
Heptabarbital
Phenobarbital
.Heptobarbital
Hexabarbital 50
Methylphenobarbital
147
143
154
137
126
130
130
132
111
115'
108
109
80
75
84
78
216
202
208
188
214
193
169
197
177
190
191
173
169
165
165
183
135
159
137
115
121
107
110
273
274
266
240
254
237
241
236
245
195
215
205
152
165
137
310 325
302
268 289
273
263
260
236 274
•
245
244
254
191
*) 1,1 mi Serum used in procedure.
l) The barbiturate concentrations arc obtained by mixing serum in different rations with
barbiturate solutions containing 200 mg/Λ The latter are obtained by dissolving 40 mg
barbiturate in 4.0 ml of 0.1 Ν NaOH and mixing 0.2 ml of this solution with 10 ml serum.
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Fig. 3 a
Absorption difference curves of barbiturates at 240 ιημ between
aqueous solutions of pH 10 and pH 2, obtained from sera con-
taining various barbiturates of different concentrations
0.300-
α o prob orbital (A)
o o pentobarbifal (N)
A A hepfabarbifol (M)
o o phenoborbi/o/ (L)
50 75 100 125 150
mg Barbiturate /1 Serum
Fig.3b
Absorption difference curves of barbiturates at 240 m^u between
aqueous solutions of pH 10 and pH 2, obtained from sera con-
taining various barbiturates of different concentrations
drawn through this point. The standard deviation of
these blank values was 0.010. From figure 3 it is shown
that on this basis the accuracy of the determination is not
better than ± 10 mg// serum for barbital. Low barbi-
turate concentrations therefore cannot be determined by
this method. Since comatosis begins to appear at an
"intermediate-acting" barbiturate concentration of 60
till 70 mg// serum, the method is suitable for use in a
moderate or severe case of barbiturate poisoning.
Especially when the kind of barbiturate can be identified,
the intoxication can be confirmed with a high degree of
certainty, because it is unlikely that an interfering sub-
stance has the same parameters as a barbiturate. Acetyl-
acetic acid also shows absorption in the barbiturate
region, although there is no maximum at 240 πιμ. How-
ever, in sera from diabetic patients the absorption of this
substance does not seriously disturb the barbiturate
identification and determination.
Conclusion
The identification of barbiturates at relative high concen-
trations in serum can be performed spectrophoto-
metrically. Of various known barbiturates, the greater
part can be identified with certainty, leaving two or
three possible substances. A case barbiturate poisoning
can be established with a high degree of certainty and its
quantitative determination can be performed with more
precision if the barbiturate present in serum is known.
My thanks are due to Drs. H. J. PETERS of St. Canisius Hospital
and Drs. P. J. J. VAN MUNSTER of the Pediatric Clinic of the
University of Nijmegen, for their interest and helpfull criticism.
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